Bioceres Crop Solutions Corp. · BCBA:BIOXC

Bioceres Crop Solutions Corp. financial statements

Bioceres Crop Solutions Corp.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue237.8M335.1M464.8M420.1M334.8M209.5M173.1M160.6M133.5M93.7M
Cost of revenue155.4M203.4M278.2M235.5M208.4M118.6M93.6M87.0M77.1M59.9M
Gross profit82.4M131.7M186.6M184.6M126.5M90.9M79.5M73.6M56.4M33.8M
Research and development11.0M14.9M17.2M15.3M6.95M5.62M4.20M3.69M3.95M3.98M
Selling, general and administrative49.3M123.1M123.7M113.0M77.5M47.6M38.3M39.2M35.3M25.3M
Operating income100.0K-2.24M45.9M54.2M39.9M38.4M39.1M32.1M15.7M-706.9K
Depreciation and amortization15.8M5.99M5.76M4.83M3.77M3.05M2.01M2.45M2.23M4.61M
EBITDA15.9M3.75M51.6M59.0M43.6M41.4M41.2M34.5M17.9M3.90M
Interest expense50.9M28.8M26.9M23.8M17.9M21.2M20.9M23.4M17.2M14.9M
Income before tax-51.0M-57.6M11.1M19.1M14.1M10.5M6.44M-9.37M-25.2M-22.4M
Income tax3.40M1.27M3.78M-1.07M18.0M14.4M2.21M6.99M-10.9M-5.63M
Net income-230.3M-55.4M4.28M18.8M-7.20M-6.87M3.36M-18.4M-11.0M-11.8M
Earnings per share, basic-3.62-0.880.070.30-0.17-0.180.09-0.60-0.39-0.42
Earnings per share, diluted-0.880.070.30-0.17-0.180.09-0.60-0.39

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents11.2M32.7M44.5M48.1M33.5M36.0M42.5M3.45M2.22M1.68M
Short-term investments1.00M2.04M11.7M11.9M5.14M10.7M28.8M356.2K12.5K4.28K
Receivables111.7M165.9M207.3M158.0M111.8M88.8M73.5M59.2M52.9M41.7M
Inventory46.7M87.6M125.9M140.4M126.0M61.0M29.3M27.3M19.4M31.3M
Current assets215.2M308.3M408.7M397.1M297.7M211.5M164.7M98.2M85.3M87.8M
Property, plant and equipment74.6M74.6M67.9M49.9M48.0M41.5M43.8M40.2M46.2M
Goodwill36.1M112.2M112.2M112.2M36.1M28.8M25.5M29.8M14.4M25.1M
Total assets471.3M763.6M852.5M818.1M518.2M394.6M297.6M242.5M196.6M239.9M
Accounts payable57.6M96.4M168.7M150.8M125.8M72.1M57.3M40.6M27.7M22.3M
Current liabilities267.0M338.0M329.3M298.7M222.7M168.0M130.6M116.5M118.7M69.4M
Long-term debt60.0M38.2M42.1M60.7M74.2M48.0M41.2M37.1M25.7M41.0M
Total debt236.8M157.9M178.9M168.3M145.5M124.8M10.4M103.6M91.0M75.0M
Total liabilities407.2M468.4M501.2M487.6M359.9M304.3M236.8M180.4M163.5M160.1M
Shareholders' equity39.1M265.4M315.0M298.6M127.4M67.7M46.2M47.3M13.7M38.3M
Shares outstanding63.6M63.2M63.5M63.2M42.3M39.2M36.4M30.5M28.1M28.1M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations52.6M49.9M41.7M2.59M-17.5M-6.21M9.32M29.7M18.4M19.1M
Capital spending-1.05M-5.64M-9.79M-11.4M-3.46M-2.81M-1.65M-2.04M-2.79M-1.39M
Free cash flow51.6M44.3M31.9M-8.77M-21.0M-9.01M7.67M27.7M15.6M17.7M
Cash from investing-5.86M-6.13M-28.7M-25.7M2.90M-8.31M-7.80M-3.26M-8.22M-20.2M
Cash from financing-65.3M-50.7M-10.1M33.0M14.8M7.36M33.5M-26.9M-10.5M2.33M
Dividends paid0-72.1K-174.8K-452.1K0-1.03M0000
Share buybacks0-926.9K-734.4K-3.00M-3.00M-3.50M-30.9K-30.9K00
Change in cash-21.5M-6.93M2.93M9.82M211.2K-7.16M35.0M-512.2K-290.6K1.39M